A comparison of intravenous methylprednisolone and hydrocortisone for the treatment of acute inflammatory bowel disease.

Abstract

Despite widespread recommendations and use of intravenous corticosteroids (IVCS) for the treatment of acute flares of ulcerative colitis and Crohn's disease, limited evidence exists comparing outcomes of the two most common regimens, intravenous methylprednisolone (IVMP) and intravenous hydrocortisone (IVHC). IVHC has stronger mineralocorticoid effects compared with IVMP and may cause higher rates of hypokalemia. We aimed to determine differences in clinical outcomes including requirement for inpatient rescue therapy, bowel resection, and rates of hypokalemia. We conducted a multicenter cohort study of all adult patients admitted with an acute flare of inflammatory bowel disease (IBD) to the three tertiary hospitals in Auckland, New Zealand, where the protocol at each institution is either IVMP 60mg daily or IVHC 100mg four times daily. All patients requiring IVCS between 20 June 2016 and 30 June 2018 were included. The IVCS protocol was then changed at one hospital, where further data were collected for a further 12months from 30 January 2019 until 30 December 2019. There were 359 patients, including 129 (35.9%) patients receiving IVMP and 230 (64.1%) patients receiving IVHC. IVMP treatment was associated with a greater requirement for rescue therapy than IVHC (36.4% vs 19.6%, P=0.001; odds ratio [OR]=2.79; 95% confidence interval [CI], 1.64-4.75, P<0.001), but also reduced rates of hypokalemia (55.8% vs 67.0%, P=0.04; OR=0.49; 95% CI, 0.30-0.81, P=0.005). There was no difference between treatment groups for the median length of admission (5days, interquartile range [IQR] 3-8), median duration of IVCS treatment (3days, IQR 2-5), or bowel resection within 30days of admission (12.4% vs 11.7%; OR=1.04). For the treatment of an acute flare of IBD, treatment with IVMP results in significantly more requirement for inpatient rescue biologic or cyclosporin. In addition, it causes statistically significant less hypokalemia than IVHC, although in practice differences are negligible.